Back to All Events

FDA: Workshop on Evaluating RWE from Observational Studies in Regulatory Decision-Making


Visit the FDA site for more information and to register for this event HERE.

Previous
February 4

Federal Notice Comment Drafting Session 2
Next
February 18

FDA: Conversations on Cancer Black History Month Panel Discussion, “Living with Cancer While Black Clinical Trial Barriers, Part Two”